OrthoPediatrics (KIDS) Stock Price, News & Analysis

Company Overview

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis. OrthoPediatrics also offers unique epiphysiodesis and guided growth devices designed to correct limb length discrepancies and angular deformities in growing children. These devices are supported by accompanying instrumentation that simplifies surgical technique and enhances procedural efficiency.

OrthoPediatrics markets its products through a direct sales organization in the United States and through distributors and regional offices in Europe, Latin America and the Asia-Pacific region. The company collaborates with leading pediatric orthopedic surgeons and academic institutions to advance clinical research, refine surgical protocols and expand its product offerings. Continuous investment in R&D underpins its strategy to fill gaps in pediatric care that are often overlooked by general orthopedic manufacturers.

Led by a management team with deep expertise in the orthopedic device industry, OrthoPediatrics emphasizes quality systems, regulatory compliance and physician education. The company’s global footprint and specialized focus on the pediatric segment position it as a growing participant in the niche market of children’s orthopedics, striving to improve clinical outcomes and quality of life for young patients worldwide.

Key Stats

• Today's Range: $16.60 to $17.66
• 50-Day Range: $14.64 to $19.22
• 52-Week Range: $14.42 to $23.70
• Volume: 202,568 shs
• Average Volume: 191,121 shs
• Market Capitalization: $439.64 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $24.44
• Consensus Rating: Moderate Buy

OrthoPediatrics Stock Analysis - MarketRank™

OrthoPediatrics scored higher than 64% of companies evaluated by MarketBeat, and ranked 284th out of 857 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

OrthoPediatrics has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on 1 strong buy rating, 8 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

OrthoPediatrics has a consensus price target of $24.44, representing about 42.8% upside from its current price of $17.12.

Amount of Analyst Coverage

OrthoPediatrics has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for OrthoPediatrics are expected to grow in the coming year, from ($1.13) to ($0.98) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of OrthoPediatrics is -10.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of OrthoPediatrics is -10.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

OrthoPediatrics has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.55% of the float of OrthoPediatrics has been sold short.

Short Interest Ratio / Days to Cover

OrthoPediatrics has a short interest ratio ("days to cover") of 6.95.

Change versus previous month

Short interest in OrthoPediatrics has recently decreased by 2.23%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

OrthoPediatrics does not currently pay a dividend.

Dividend Growth

OrthoPediatrics does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.49

News Sentiment

OrthoPediatrics has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 14 news articles for OrthoPediatrics this week, compared to 2 articles on an average week.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, OrthoPediatrics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,003,450.00 in company stock.

Percentage Held by Insiders

32.70% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

69.05% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

KIDS Stock Analysis - Frequently Asked Questions

How have KIDS shares performed this year?

OrthoPediatrics' stock was trading at $17.76 at the beginning of 2026. Since then, KIDS stock has decreased by 3.6% and is now trading at $17.12.

How were OrthoPediatrics' earnings last quarter?

OrthoPediatrics Corp. (NASDAQ:KIDS) released its quarterly earnings results on Thursday, April, 30th. The company reported ($0.42) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.46) by $0.04. The company had revenue of $59.36 million for the quarter, compared to analyst estimates of $58.29 million. OrthoPediatrics had a negative trailing twelve-month return on equity of 7.01% and a negative net margin of 16.31%.
Read the conference call transcript.

When did OrthoPediatrics IPO?

OrthoPediatrics (KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.

Who are OrthoPediatrics' major shareholders?

Top institutional shareholders of OrthoPediatrics include Wasatch Advisors LP (1.30%), Riverbridge Partners LLC (1.04%), Conestoga Capital Advisors LLC (0.25%) and Bank of New York Mellon Corp (0.19%). Insiders that own company stock include David R Bailey, Fred Hite, Joseph W Hauser, Gregory A Odle, Daniel J Gerritzen, Mark C Throdahl and Terry D Schlotterback.
View institutional ownership trends.

How do I buy shares of OrthoPediatrics?

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of OrthoPediatrics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that OrthoPediatrics investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

• Last Earnings: 4/30/2026
• Today: 5/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:KIDS
• CIK: 1425450
• Web: www.orthopediatrics.com
• Phone: (574) 268-6379
• Fax: 574-269-3692
• Employees: 200
• Year Founded: 2006

Price Target and Rating

• Average Price Target for OrthoPediatrics: $24.44
• High Price Target: $34.00
• Low Price Target: $17.00
• Potential Upside/Downside: +42.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.82
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.68)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$39.65 million
• Net Margins: -16.31%
• Pretax Margin: -16.27%
• Return on Equity: -7.01%
• Return on Assets: -4.86%

Debt

• Debt-to-Equity Ratio: 0.29
• Current Ratio: 5.21
• Quick Ratio: 2.65

Sales & Book Value

• Annual Sales: $236.35 million
• Price / Sales: 1.86
• Cash Flow: $0.17 per share
• Price / Cash Flow: 102.47
• Book Value: $13.19 per share
• Price / Book: 1.30

Miscellaneous

• Outstanding Shares: 25,680,000
• Free Float: 17,287,000
• Market Cap: $439.64 million
• Optionable: Optionable
• Beta: 0.99